Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists

Reaction Biology Corporation (United States)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

669
total citations
FWCI
19.35
Percentile
100%
References
44
Citations per year

Authors

7

Topics & keywords

Keywords
  • Etanercept
  • Infliximab
  • Tumor necrosis factor alpha
  • Medicine
  • Immunology
  • Psoriasis
  • Monoclonal antibody
  • Pharmacology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.